ClearPoint Neuro (CLPT) Projected to Post Earnings on Wednesday

ClearPoint Neuro (NASDAQ:CLPT) is expected to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $8.23 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

ClearPoint Neuro Trading Down 4.2 %

CLPT stock opened at $16.72 on Monday. ClearPoint Neuro has a 12 month low of $5.11 and a 12 month high of $19.22. The firm has a market capitalization of $461.14 million, a P/E ratio of -24.23 and a beta of 1.03. The firm has a 50 day moving average of $16.61 and a 200-day moving average of $13.67.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Lake Street Capital lifted their target price on shares of ClearPoint Neuro from $17.00 to $30.00 and gave the company a “buy” rating in a research report on Tuesday, January 21st. B. Riley lifted their target price on shares of ClearPoint Neuro from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Tuesday, January 28th.

ClearPoint Neuro Company Profile

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.